What we know about the super-rare blood clots linked to the J&J vaccine
Experts are figuring out how to rapidly diagnose and treat the unusual clots linked to both the Johnson & Johnson and AstraZeneca shots.
Scientists are beginning to unravel what is sparking the rare but severe blood clotting reaction that has now been associated with both the Johnson & Johnson and the AstraZeneca coronavirus vaccines.
Unlock this story for free
Create an account to read the full story and get unlimited access to hundreds of Nat Geo articles.